XRHealth
OperatingXRHealth, Inc.
Healthcare · Technology · Brookline, DE · Founded 2020
On-demand virtual care reinvented
Financials
FY2019–FY2021 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inBlue bars are the pre-money valuation the company stated for a priced round.
Share price over rounds
Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.
Cap table
Principal holders% as the filing states it, Apr 29, 2022
- ESOP Management & Trust Services Ltd.800,000 Common Stock23.7%of
- Eran Orr16,390 Common Stock0.49%of
Sold to the crowd
- Reg CF · Nov 20218,393 shares at $25.63$215.1K· 111 investors
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
8 people
After more than 13 years at the Venture Capital Industry and 4 years as the Managing Director of The Portland Trust Israel, a nonprofit 'action-tank" that leads economic development projects in the undeserved population in Israel, Gal recently established Bridges Israel, together with his two partners. Bridges Israel an impact investments fund that invest in businesses that operate among the underserved population in Israel as well as in "tech-for good" Start-ups
Gilad is a serial entrepreneur and active angel investor. He currently acts as a board member and the CFO of Cupixel. Before that Gilad founded and was the CEO of Neura (acquired by Otonomo Technologies) and Spicebox Labs. Gilad is also a director in publicly traded Third Eye Systems (TASE: THES).
Entrepreneur with more than 40 years of experience managing and funding the commercial global introduction of innovative and revolutionary medical and life science technologies. After a successful career as an entrepreneur starting many companies that were either sold or went public, in 2005 Hillel founded 20/20 HealthCare Partners, an investment company where he is the Managing Partner.
Technology entrepreneur and investor with more than 20 years of experience. Sergey has a lot of experience across such sectors as software development, VoIP, cybersecurity, digital health, finance, and others. Today Sergey is an investor, board member, or mentor in several startups across US and Israel. Sergey holds an MBA, Sloan Fellow from MIT and B.Sc. in Computer Science, Cum Laude from Beer-Sheva University.
Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 1 of 5 annual reports (FY2021–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 12 filings on EDGAR- Form DSep 16, 20260001892473-26-000007EDGAR
- Form DSep 16, 20260001892473-26-000008EDGAR
- Form DSep 15, 20260001892473-26-000006EDGAR
- Form DSep 10, 20260001892473-26-000004EDGAR
- Form DSep 10, 20260001892473-26-000005EDGAR
- Form C-TRSep 6, 20240001665160-24-001295EDGAR
- Form C-USep 30, 20220001665160-22-002545EDGAR
- Form C-ARApr 29, 20220001665160-22-001301EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.